Fibrosarcoma
📧 Sign up to get email alerts when something new happens for Fibrosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Infantile Versus Adult-type Fibrosarcoma and the Risk of Multiple Primary Malignancies
This clinical trial update reports results comparing infantile fibrosarcoma with adult-type fibrosarcoma. It also assesses the risk of devel…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Phase 1, Phase 2]
A pediatric Phase 1/2 study assessed the safety and early activity of weekly nab-paclitaxel in children with recurrent or refractory solid t…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Bevacizumab and Radiation Therapy for Sarcomas [Phase 2]
Phase 2 trial evaluating bevacizumab with radiation therapy in soft tissue sarcomas completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update for romidepsin (depsipeptide) in patients with metastatic or unresectable soft tissue sarcoma, with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
A Phase 2 trial evaluating saracatinib (AZD0530) in adults with recurrent, locally advanced, or metastatic soft tissue sarcoma has completed…
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma [Phase 2]
Phase 2 trial evaluating cixutumumab with temsirolimus in pediatric patients with recurrent or refractory sarcomas has been completed with r…
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung [Phase 2]
Phase 2 study evaluating REOLYSIN (pelareorep) for bone and soft tissue sarcomas metastatic to the lung has been completed, assessing safety…
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers [Phase 2]
This Phase 2 trial evaluates high-dose chemotherapy with bone marrow or stem cell transplant for rare poor-prognosis cancers. The study incl…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma [Phase 2]
A Phase 2 trial evaluating surgery and/or chemotherapy for pediatric fibrosarcoma (infantile/congenital/childhood) was terminated, with resu…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S9624 Ifosfamide in Treating Patients With Meningeal Tumors [Phase 2]
Phase 2 SWOG trial of ifosfamide for meningeal tumors and related sarcomas was terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans [Phase 2]
Phase 2 trial evaluating imatinib mesylate in patients with locally recurrent or metastatic dermatofibrosarcoma protuberans.
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma [Phase 2]
Phase II trial results for sunitinib malate in metastatic or surgically unresectable soft tissue sarcoma were posted, evaluating activity ac…